Valuation: Incyte Corporation

Market Cap 2.44TCr 2.11TCr 1.97TCr 1.81TCr 3.41TCr 2,32600Cr 3.46TCr 23TCr 9.09TCr 1,16600Cr 9.18TCr 8.98TCr 3,85400Cr P/E 2026 *
53.8x
P/E 2027 * 16.8x
Enterprise Value 2.02TCr 1.75TCr 1.63TCr 1.5TCr 2.81TCr 1,92100Cr 2.86TCr 19TCr 7.51TCr 96TCr 7.58TCr 7.42TCr 3,18400Cr EV / Sales 2026 *
3.4x
EV / Sales 2027 * 2.98x
Free-Float
98.14%
Yield 2026 *
-
Yield 2027 * -
1 day+1.84%
1 week+0.87%
Current month+0.87%
1 month+2.13%
3 months+23.31%
6 months+11.23%
Current year+22.06%
1 week 115.77
Extreme 115.77
124.57
1 month 110.56
Extreme 110.56
132.6
Current year 89.25
Extreme 89.25
132.6
1 year 78.2
Extreme 78.2
132.6
3 years 50.27
Extreme 50.27
132.6
5 years 50.27
Extreme 50.27
132.6
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 26/06/2025
Director of Finance/CFO 57 04/05/2026
President 62 05/06/2023
Director TitleAgeSince
Chairman 59 26/06/2025
Director/Board Member 72 20/01/2015
Director/Board Member 64 20/01/2015
Date Insider Type Main position Quantity % Market Cap.
03/08/26 Fiscal year

EVP & Chief Scientific Officer

18,165 0.0091%
31/07/26 Sell

Chairperson

-15,888 0.0080%
23/07/26 Free

Chief Technology Officer

15,425 0.0077%
Change 5-day change 1-year change 3-year change Capi.($)
+1.84%+0.87%+54.17%+85.73% 2.44TCr
+1.59%+2.85%+40.11%+1.24% 7.83TCr
+2.77%+4.78%-1.65%+27.62% 5.11TCr
-0.84%+0.09%+20.92%+179.15% 4.92TCr
-0.13%+7.42%-50.22%-49.58% 4.47TCr
+0.80%+2.46%+62.77%-23.33% 3.07TCr
+9.86%+7.94%+122.36%-41.53% 2.36TCr
+4.29%+9.40%+3.77%+226.51% 2.1TCr
+1.66%-3.70%+65.40%+123.91% 1.66TCr
+2.03%+5.48%+83.85%+172.87% 1.65TCr
Average +2.39%+4.22%+40.15%+70.26% 3.56TCr
Weighted average by Cap. +1.89%+4.35%+29.57%+51.03%

Financials

2026 *2027 *
Net sales 594.25Cr 514.03Cr 480.03Cr 440.35Cr 828.25Cr 57TCr 841.4Cr 5.63TCr 2.21TCr 28TCr 2.23TCr 2.18TCr 94TCr 625.52Cr 541.08Cr 505.28Cr 463.52Cr 871.83Cr 60TCr 885.68Cr 5.93TCr 2.33TCr 30TCr 2.35TCr 2.3TCr 99TCr
Net income 47Cr 40Cr 38Cr 35Cr 65Cr 4.43TCr 66Cr 441.27Cr 173.2Cr 2.22TCr 174.84Cr 171.02Cr 7.34TCr 147.04Cr 127.19Cr 118.78Cr 108.96Cr 204.94Cr 14TCr 208.19Cr 1.39TCr 546.96Cr 7.01TCr 552.16Cr 540.08Cr 23TCr
Net Debt -424.92Cr -367.56Cr -343.24Cr -314.88Cr -592.24Cr -40TCr -601.65Cr -4.03TCr -1.58TCr -20TCr -1.6TCr -1.56TCr -67TCr -581.22Cr -502.75Cr -469.5Cr -430.69Cr -810.08Cr -55TCr -822.95Cr -5.51TCr -2.16TCr -28TCr -2.18TCr -2.13TCr -92TCr
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
07/26/07 $120.56 +1.84% 15,40,373
06/26/06 $118.38 -1.19% 23,90,460
05/26/05 $119.80 -0.66% 17,95,673
04/26/04 $120.60 +1.83% 20,77,654
03/26/03 $118.43 -0.91% 14,19,133
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
27
Last Close Price
120.56USD
Average target price
124.96USD
Spread / Average Target
+3.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock